On March 11, the hospital reported that a 31-year-old Israeli national was admitted to the emergency room in the middle of the night with severe chest and epigastric pain. Imaging results revealed a ...

Prostate cancer is one of the most common cancers among men. Many cases grow slowly and may never become life-threatening. Because of this, doctors often recommend a management approach called “active ...

Dr. Matthew Galsky spoke with CURE about the KEYNOTE-B15 trial results and their potential impact on muscle-invasive bladder cancer care. At the 2026 ASCO Genitourinary Cancers Symposium, the ...

KEYNOTE-B15 compared perioperative enfortumab vedotin plus pembrolizumab against neoadjuvant cisplatin-based chemotherapy in cisplatin-eligible MIBC, using event-free survival as the primary endpoint.

Lauren Ver Steeg isn’t afraid to crack a butt joke. After being diagnosed with stage 3 rectal cancer at 26, she’s made a conscious effort to talk openly about the often-taboo topics that surround the ...